Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18896739 | DEVICE AND PROCESS FOR PREPARING SEBACIC ACID THROUGH ELECTROMAGNETIC INDUCTION HEATING COUPLED WITH DRY CONSTANT-TEMPERATURE ALKALINE HYDROLYSIS | September 2024 | January 2025 | Allow | 4 | 1 | 0 | No | No |
| 18716802 | LOW BIURET UREA PRODUCTION | June 2024 | February 2025 | Allow | 8 | 1 | 0 | No | No |
| 18650059 | GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptor | April 2024 | April 2025 | Allow | 12 | 1 | 0 | Yes | No |
| 18378221 | CATHEPSIN INHIBITORS | October 2023 | March 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18454685 | CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGS | August 2023 | March 2025 | Allow | 19 | 1 | 0 | Yes | No |
| 18349727 | CHEMOSELECTIVE THIOL-CONJUGATION WITH ALKENE OR ALKYNE-PHOSPHONAMIDATES | July 2023 | August 2024 | Allow | 13 | 1 | 0 | No | No |
| 18212456 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | June 2023 | September 2024 | Allow | 15 | 0 | 0 | Yes | No |
| 18317768 | GENERATION OF PEROXYFORMIC ACID THROUGH POLYHYDRIC ALCOHOL FORMATE | May 2023 | June 2025 | Allow | 25 | 4 | 0 | Yes | No |
| 18141994 | UREA SYNTHESIS FROM GREENHOUSE GAS AND NITROGEN VIA TRANSITION METAL-FREE CATALYSIS OVER GRAPHITIC CARBON NITRIDE | May 2023 | June 2025 | Abandon | 26 | 5 | 0 | No | No |
| 18299605 | Method for Preparing L-Glufosinate | April 2023 | October 2024 | Abandon | 18 | 1 | 0 | No | No |
| 18245317 | PROCESS FOR ACID HYDROLYSIS OF PURE POLYLAUROLACTAM | March 2023 | May 2025 | Allow | 26 | 0 | 0 | No | No |
| 18043268 | METHOD FOR PREPARING GUANIDINO ACETIC ACID | February 2023 | May 2025 | Allow | 26 | 1 | 0 | Yes | No |
| 18106305 | Inhibitors of Dihydroceramide Desaturase For Treating Disease | February 2023 | October 2024 | Allow | 21 | 1 | 1 | No | No |
| 18106073 | OXYSTEROLS AND METHODS OF USE THEREOF | February 2023 | August 2024 | Allow | 18 | 1 | 0 | No | No |
| 18067293 | CONTINUOUS-FLOW SYNTHESIS METHOD OF 13C-UREA | December 2022 | May 2025 | Abandon | 29 | 4 | 0 | No | No |
| 17784533 | METHOD FOR THE INDUSTRIAL PREPARATION OF THE DISODIUM SALT OF ((2S)-3-([1,1'-BIPHENYL]-4-YL)-2-((HYDROXY((1R)-1-(((1-(ISOBUTYRYLOXY)ETHOXY)CARBONYL)AMINO)ETHYL)PHOSPHORYL) METHYL)PROPANOYL)-L-ALANINE | June 2022 | March 2025 | Allow | 34 | 0 | 0 | No | No |
| 17825689 | PROCESS FOR THE SYNTHESIS OF CALEBIN-A AND ITS INTERMEDIATES | May 2022 | October 2024 | Allow | 29 | 1 | 0 | No | No |
| 17433700 | METHOD FOR PROCESSING BENZENE POLYCARBOXYLIC ACID ESTERS AND USE OF SAME TO PRODUCE CYCLOHEXANE POLYCARBOXYLIC ACID ESTERS | April 2022 | June 2025 | Allow | 45 | 1 | 0 | Yes | No |
| 17724969 | ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS | April 2022 | October 2024 | Abandon | 30 | 2 | 1 | No | No |
| 17693620 | INHIBITOR OF EIF2alpha DEPHOSPHORYLATION | March 2022 | June 2025 | Allow | 39 | 1 | 0 | No | No |
| 17639122 | AN N,N-DIHYDROCARBONYLAMIDE CARBOXYLIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF | March 2022 | May 2025 | Allow | 38 | 0 | 1 | Yes | No |
| 17627626 | METHOD FOR PRODUCING ALPHA-ACYLOXYCARBOXYLIC ACID ESTER | January 2022 | April 2025 | Allow | 39 | 1 | 0 | No | No |
| 17623723 | NEW STABLE FORMULATIONS OF 1-Z-BROMOALK-1-ENE COMPOUNDS AND USE THEREOF IN THE MANUFACTURE OF PHEROMONES | December 2021 | December 2024 | Allow | 36 | 0 | 0 | No | No |
| 17622834 | METHOD FOR RACEMIC PREPARATION OF CHIRAL B-AMINO ACIDS AND DERIVATIVES THEREOF | December 2021 | April 2025 | Abandon | 39 | 4 | 0 | No | No |
| 17596381 | PROCESS FOR THE PRODUCTION OF DIACYL PEROXIDES | December 2021 | September 2024 | Allow | 33 | 0 | 0 | Yes | No |
| 17526759 | METHOD FOR PRODUCING SOLID UREA BY GRANULATION | November 2021 | May 2025 | Allow | 42 | 3 | 1 | No | No |
| 17438915 | PROCESS AND APPARATUS FOR UREA PRODUCTION | September 2021 | December 2024 | Allow | 39 | 0 | 1 | Yes | No |
| 17438091 | METHODS FOR FUNCTIONALIZATION HYDROCARBONS | September 2021 | May 2025 | Allow | 44 | 2 | 1 | Yes | No |
| 17435831 | LIGANDS FOR PRODUCTION OF 1-OCTENE IN CHROMIUM ASSISTED ETHYLENE OLIGOMERIZATION PROCESS | September 2021 | June 2025 | Allow | 45 | 2 | 1 | Yes | No |
| 17435731 | Process for preparing {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate having high purity | September 2021 | August 2024 | Allow | 35 | 2 | 1 | Yes | No |
| 17182413 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF | August 2021 | March 2025 | Allow | 49 | 1 | 1 | Yes | No |
| 17423273 | AGENT FOR INITIATING A RADICAL ADDITION REACTION AND PROCESS USING IT | July 2021 | May 2025 | Allow | 46 | 3 | 0 | No | No |
| 17420886 | SALT-FREE PRODUCTION OF METHIONINE FROM METHIONINE NITRILE | July 2021 | August 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17357061 | METHOD FOR PRODUCING FLUOROALKOXIDE | June 2021 | March 2025 | Allow | 45 | 5 | 1 | Yes | No |
| 17417599 | COMPOSITION FOR PRODUCING N-VINYL CARBOXYLIC ACID AMIDE | June 2021 | October 2024 | Allow | 40 | 2 | 0 | Yes | No |
| 17416489 | A process for preparation of amides and esters of 2-((2-hydroxypropanoyl)oxy)propanoic acid | June 2021 | May 2025 | Allow | 46 | 4 | 0 | No | No |
| 17414995 | OXIDATIVE PREPARATION OF MALEIC ACID | June 2021 | July 2024 | Allow | 37 | 2 | 0 | No | No |
| 17415271 | PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSINE SOLUTION | June 2021 | June 2025 | Allow | 48 | 3 | 1 | No | No |
| 17413540 | METHOD FOR PRODUCING METHIONINE | June 2021 | August 2024 | Allow | 38 | 2 | 0 | Yes | No |
| 17298477 | FLUORESCENT PROBE FOR DETECTING CARBOXYPEPTIDASE ACTIVITY | May 2021 | September 2024 | Allow | 39 | 1 | 0 | Yes | No |
| 17291908 | NEGATIVELY CHARGED PEG-LIPID CONJUGATES | May 2021 | April 2025 | Allow | 47 | 1 | 1 | Yes | No |
| 17208092 | Biocidal Compound | March 2021 | January 2025 | Abandon | 46 | 3 | 1 | Yes | No |
| 17113343 | Calcium-based Catalyst and Method for Catalytically Synthesizing Alkanolamide Surfactant thereof | December 2020 | September 2024 | Allow | 45 | 2 | 1 | Yes | No |
| 17046432 | UREA MANUFACTURING METHOD | October 2020 | April 2025 | Abandon | 54 | 3 | 0 | No | No |
| 16760684 | SPIRO COMPOUNDS AS MALODOR COUNTERACTING INGREDIENTS | April 2020 | November 2024 | Allow | 54 | 2 | 1 | Yes | No |
| 16204413 | METHOD FOR PREPARING N-[4-(2-{[2-(4-METHANE SULFONAMIDOPHENOXY) ETHYL](METHYL)AMINO}ETHYL)PHENYL]METHANESULFONAMIDE (DOFETILIDE) | November 2018 | June 2019 | Allow | 6 | 0 | 0 | No | No |
| 16113624 | PROCESS FOR PREPARING BIPHENYLAMINES FROM ANILIDES BY RUTHENIUM CATALYSIS | August 2018 | October 2018 | Allow | 2 | 0 | 0 | Yes | No |
| 16076486 | AN IMPROVED PROCESS FOR THE PREPARATION OF LACOSAMIDE | August 2018 | June 2019 | Allow | 10 | 1 | 0 | Yes | No |
| 16070111 | FLUORINE ATOM-CONTAINING COMPOUND AND USE THEREOF | July 2018 | February 2019 | Allow | 7 | 0 | 0 | Yes | No |
| 15740245 | METHOD FOR THE PREPARATION OF ALKYLSALICYLALDEHYDE AND ALKYLSALICYLALDOXIME, AND USE THEREOF | December 2017 | October 2018 | Allow | 10 | 1 | 0 | Yes | No |
| 15547772 | MANUFACTURE OF A CHARGE DIRECTOR | July 2017 | July 2018 | Allow | 12 | 1 | 0 | Yes | No |
| 15506611 | RECOVERY PROCESS FOR FUNCTIONALIZED COMPOUND REACTION PRODUCT | February 2017 | January 2020 | Allow | 34 | 3 | 1 | Yes | No |
| 15305865 | PROCESS FOR PREPARING BIPHENYLAMINES FROM ANILIDES BY RUTHENIUM CATALYSIS | October 2016 | April 2018 | Allow | 18 | 1 | 1 | Yes | No |
| 15126526 | AN IMPROVED PROCESS FOR THE SYNTHESIS OF DIMETHYL FUMARATE | September 2016 | January 2020 | Allow | 40 | 4 | 0 | Yes | No |
| 14423963 | SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B | February 2015 | September 2016 | Allow | 18 | 3 | 0 | Yes | No |
| 13094657 | Process for Removing Water From Alcohol Mixtures | April 2011 | February 2014 | Allow | 34 | 1 | 0 | No | No |
| 12377000 | 2, 2', 6, 6'- TETRASUBSTITUTED AMINOPHOSPHINE LIGAND AND ITS SYNTHESIS METHOD | June 2009 | January 2014 | Allow | 59 | 0 | 1 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner BONAPARTE, AMY C works in Art Unit 1692 and has examined 54 patent applications in our dataset. With an allowance rate of 87.0%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.
Examiner BONAPARTE, AMY C's allowance rate of 87.0% places them in the 61% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by BONAPARTE, AMY C receive 1.65 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by BONAPARTE, AMY C is 36 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +24.1% benefit to allowance rate for applications examined by BONAPARTE, AMY C. This interview benefit is in the 74% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 31.5% of applications are subsequently allowed. This success rate is in the 57% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 38.9% of cases where such amendments are filed. This entry rate is in the 52% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 83% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 8.5% of allowed cases (in the 86% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.